Johannesburg Stock Exchange
Aspen Pharmacare Holdings Ltd · APNJ.J
Price history
Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded multinational pharmaceutical company. The Company focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. Its segments include Prescription, Over the counter (OTC), Injectables, Active Pharmaceutical Ingredients (API), Finished Dose Form (FDF) and Heparin. It offers sterile products in injectable form primarily administered in hospitals and also those prescribed and administered by either physicians or in a retail pharmacy environment. Its key brands include Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon and Xylocaine (Injectables). Its OTC segment includes products that do not require prescriptions and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors.
Fundamentals
| Metric (ZAR, M) | 2026 2026 | 2001 2001 |
|---|---|---|
| Revenue Total Revenue |
45
↗APNJ.J:Key Stats:APNJ.J:Key Stats:11 Page: — · Key Stats|Key Financials¹ Total Revenue: 45019200.5800 → Total Revenue |
|
| EBITDA |
11
↗APNJ.J:Key Stats:APNJ.J:Key Stats:11 Page: — · Key Stats|Key Financials¹ EBITDA: 10720913.3800 → EBITDA |
|
| EBIT |
8
↗APNJ.J:Key Stats:APNJ.J:Key Stats:11 Page: — · Key Stats|Key Financials¹ EBIT: 8011858.0800 → EBIT |
|
| Net income Net Income |
6
↗APNJ.J:Key Stats:APNJ.J:Key Stats:11 Page: — · Key Stats|Key Financials¹ Net Income: 5558266.7100 → Net Income |
|
| Operating margin | 18% | |
| Net margin | 12% |